Efficacy and Safety of Baclofen for Maintenance of Abstinence in Alcohol Dependent Patients
Status:
Completed
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess the efficacy of Xylka® (baclofen) compared to placebo
on continuous abstinence rate during 20 weeks of treatment, after withdrawal, in alcohol
dependent patients receiving Brenda therapy sessions.